The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
The best opportunity to learn and discuss common issues and interests directly with peers.
Ian Nicoud
LURIS, Netherlands
The course exceeded my expectations. We exchanged experiences and learned different options of approaches to existing problems.
Patricia Lima
Instituto Superior Technico, Portugal
It is always encouraging to see that other TTOs are encountering the same problems that we do!
Aurore De Boom
Université Libré de Bruxelle, Belgium
The experts, the specific content and the informal setting will improve you as a professional.
Brechtje Vreenegoor
Radboud Universteit, Netherlands
Technology transfer is ever changing and a key piece for the competitiveness of your institution, this course is an excellent tool to prepare yourself for that challenge.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
Join our newsletter and get the latest news